2019
DOI: 10.1016/j.jddst.2018.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Simulated synovial fluids for in vitro drug and prodrug release testing of depot injectables intended for joint injection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 54 publications
0
5
0
Order By: Relevance
“…Disadvantages are related to the limitation in the obtainment of adequate amounts from patients [18]. One alternative can be the use of bovine, porcine or equine SF [19] or the use of simulated SF [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…Disadvantages are related to the limitation in the obtainment of adequate amounts from patients [18]. One alternative can be the use of bovine, porcine or equine SF [19] or the use of simulated SF [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…2 ). In human SF, proteins with MW ​> ​160 ​kDa are totally absent [ 41 ]; subsequently, the cut-off of a healthy synovial membrane is lower than 160 ​kDa. Samples of the conjugate HA-ALD and the physical mixture HA ​+ ​ALD were placed in a 20 ​kDa dialysis and total released phosphorous was measured in the reservoir at different time points.…”
Section: Resultsmentioning
confidence: 99%
“…Apart from the MMPs, esterase is detected in the synovial fluid of OA patients. [75][76][77] Since the ester bonds present in TG-18 are susceptible to esterase and MMPs, we used it to achieve sustained release of BI-4394. 51 To investigate the release of the encapsulated BI-4394 in response to the enzymes, Gel@5 and Gel@10 were placed in dialysis bags containing 100 U mL À1 esterase.…”
Section: Rheologymentioning
confidence: 99%